Demystifying Value-Based Healthcare: A Physician Expert Explains All (with Real-World Examples)

Interview with Dr. Dan Mazanec

CMS has an objective to shift 50% of all reimbursement services from fee-for-service to alternative, value-based methods by 2018.  And bundled payment models, according to Dr. Dan Mazanec, will be the principal driver of this transformative initiative.

But the topic of value-based healthcare can be pretty confusing , right?  Comprehensive Care for Joint Replacement.  Medicare Access and CHIP Reauthorization Act.  MIPS vs. APM.  The list goes on and on.  How do you begin to understand it all?  And if you’re a leader within your medtech or biotech organization, how should you begin to prepare your company for the future?

To help answer some of these questions, I invited the aforementioned Dr. Dan Mazanec to join Medsider Radio.  He’s currently the Chief Medical Officer for Dorsata.  Prior to joining Dorsata, Dr. Mazanec was the Associate Director of the Center for Spine Health at the Cleveland Clinic.  Board-certified in internal medicine and rheumatology, Dan led the development and implementation of the Spine CarePath across the entire Cleveland Clinic Health System.

Interview Highlights with Dr. Dan Mazanec

  • How did the original concept of bundled payment models start?  And what was the original intent?

  • 2 early examples of bundles payments from the 80’s and 90’s.

  • An overview of the Comprehensive Care for Joint Replacement (CCJR) program and the potential ramifications for medical device companies.

  • The shifting financial risk in healthcare and why care coordination will be so important.

  • What the Medicare Access and CHIP Reauthorization Act (MACRA) means for healthcare, and more specifically, the 2 paths to reimbursement for physicians (MIPS vs. APMs).

  • How the concepts of Meaningful Use and Advancing Care Information will change and their impact on solo or small physician practices.

  • Specific to bundled payments and reimbursement, the top 2-3 things that medtech companies need to consider right now.

  • Dan’s favorite non-fiction business book, the business leader he finds most inspiring, and the one piece of advice he’d tell his 30-yr. old self.

Premium Members Only

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

You May Like These Articles

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Medsider Mentors

Medsider Mentors

Medsider Playbooks

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest

Copyright © Medsider 2024 • All rights reserved.

Subscribe

Sign In

Suggest a Guest